John Breitner

John Breitner was recruited to the Douglas to lead a new Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD). The Centre seeks measurement and detection of change in biomarkers thought to reveal the progress of presymptomatic Alzheimer’s disease. With such ability to measure change, the Centre undertakes clinical trials for Pre-symptomatic Evaluation of Novel or Experimental Treatments for AD (PREVENT-AD).

John Breitner has authored over 200 publications and has mentored more than 15 doctoral and post-doctoral students, almost all of whom have gone on to hold full-time academic appointments.


Research team

John Breitner, MD

Associate Directors
Pierre Étienne, MD
Judes Poirier, PhD


Veronique Bohbot, PhD
Serge Gauthier, MD
Vasavan Nair, MD
Judes Poirier, PhD
Jens Pruessner, PhD
Natasha Rajah, PhD
Pedro Rosa-Neto, MD, PhD
Pierre Etienne, MD
David Fontaine, PhD
Alan C. Evans, PhD
Pierre Bellec, PhD
Rick Hoge, PhD
Louis Collins, PhD
Gerhard Multhaup, PhD
Claudio Cuello, PhD


Marianne Dufour
Jennifer Tremblay-Mercier
Cécile Madjar